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Abstract
Changes in gut microbial composition have been linked to inflammatory bowel disease, obesity
and allergies in humans. A new study shows that pattern recognition of commensal bacteria by B
cells reduces allergic inflammation in mice, adding to the mounting evidence for the ‘hygiene
hypothesis’.
Twenty-three years ago, a study consisting of a single figure and insightful speculation
redefined our relationship with microbial organisms1. Over a century earlier, Koch and
Pasteur validated the germ theory of disease, effectively branding microbes as agents of
infection. This realization promoted a campaign committed to eradicating infectious diseases
by targeting their root cause. Vaccine development, antibiotic treatments, improved
sanitation practices and the adoption of a hygienic lifestyle were part of the armory in the
war against microorganisms. However, these very advances may be a Pyrrhic victory over
infectious disease as, in turn, reduced exposure to microbes seems to contribute to the
development of atopic and inflammatory disorders. In this issue of Nature Medicine, Hill et
al.2 provide experimental support for the notion that microbes may protect from allergic
disease.
In 1989, David Strachan evaluated the associated risk between allergic rhinitis and sixteen
perinatal, social and environmental factors1. He found that family size had a significant
inverse correlation with the development of allergy. Extrapolating that smaller family size
may reduce individual exposure to respiratory infections; Strachan suggested that such
infections might be protective against the development of atopic disease. From this proposal
arose the hygiene hypothesis, which redefined our relationship with the microbial world,
prompting us to better understand how microorganisms benefit host health and development.
In the decades that followed, multiple studies have supported Strachan’s suggestion that
microbial exposure may benefit host immune function. Notably, these studies have
identified the commensal microbiota (consisting of over a 100 trillion microbes that colonize
all environmentally exposed surfaces of a mammalian host) as an important modulator of
host immune responses. In particular, specific microbes in the gut have been shown to
influence intestinal immune development and protection from disease3, 4.
These effects extend beyond the gut, as microbes and their products have been shown to
affect systemic infectious and inflammatory diseases5, 6, 7. The microbiota has a crucial role
even outside the immune compartment, modulating weight gain, various endocrine disorders
*To whom correspondence should be addressed: sarkis@caltech.edu.
NIH Public Access
Author Manuscript
Nat Med. Author manuscript; available in PMC 2014 August 05.
Published in final edited form as:
Nat Med. ; 18(4): 492–494. doi:10.1038/nm.2723.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
and nociceptive recognition8, 9, 10. However, with the exception of epidemiological studies
that further support Strachan’s initial observations, very little convincing evidence has
emerged that determines whether and how the microbiota contributes to the development of
allergic disease. Hill et al.2 now provide a major leap forward by characterizing a
mechanism by which commensal bacteria may be preventing the development of atopic
disease.
Hill et al.2 show that antibiotic-mediated depletion of the microbiota is sufficient to
predispose mice to allergic disease (Fig. 1). Mice treated with wide-spectrum antibiotics had
an altered immune profile, with increases in serum concentrations of IgE and circulating
basophils, two important mediators in atopic disease. Furthermore, after respiratory
exposure to house dust mite allergen, antibiotic-treated mice showed a heightened allergic
response characterized by increased alveolar inflammation and exaggerated immune
responses consistent with allergic reaction. The phenotype in antibiotic-treated mice was
similar to that in germ-free mice, suggesting the microbiota’s influence on host immune
function is plastic since it is reversed after pharmacologic disruption of host-microbial
symbiosis.
In an elegant set of experiments, the authors decipher aspects of the molecular interplay
between specific microbial-host factors that promote proper immune development,
preventing allergic disease2. Increases in serum IgE in mice after antibiotic treatment
promoted basophil expansion and subsequent susceptibility to allergic disease. Compared to
conventionally raised mice—with an intact microbiota—both antibiotic-treated and germ-
free mice showed a higher proportion of bone marrow basophilic precursor cells and higher
expression of their proexpansion receptor CD123, as well as increased expansion of these
cells after stimulation ex vivo. The authors then sought to determine whether there was a
mechanistic link between the increased serum IgE concentration and the basophil expansion.
No increases in circulating basophils were observed after antibiotic treatment of Rag1-
knockout mice, which lack B cells, or in mice in which IgE was neutralized, suggesting that
communication between the microbiota and B cells is crucial in preventing proallergy
immune development. Intriguingly, humans with high serum IgE concentrations also have
increased basophil proportions, suggesting that IgE may regulate basophil-mediated allergic
disease.
Speculating that direct microbial sensing by immune cells affects allergy, the authors
showed that the commensal microbiota modulates B cell production of IgE antibody in a
myeloid differentiation factor 88 (MyD88)-dependent manner2. MyD88-deficient mice with
an intact microbiota showed high circulating levels of basophils and high serum IgE
concentration, similar to antibiotic-treated and germ-free mice. This phenotype was
reproduced in mice in which MyD88 expression was selectively deficient in B cells.
Furthermore, exposure of antibiotic-treated mice with the microbial molecule CpG, a Toll-
like receptor (TLR)-dependent microbial ligand, was sufficient to reduce serum IgE as well
as the frequency and total number of circulating basophils. What remains to be determined is
whether these B cells reside in systemic compartments or are located in intimate association
with the microbiota at mucosal surfaces. In other words, where (and how) do microbial
products contact B cells?
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Previous work has shown that germ-free mice show T helper type 2 skewing, an immune
profile consistent with increased allergic reactions11. Hill et al.2 uncover a link between the
microbiota and B cells, mediated through MyD88-dependent ligand reception that promotes
appropriate host immune development. The indication that MyD88-deficient mice seem
phenotypically similar to germ-free and antibiotic-treated mice suggests two things. First, if
the microbiota promotes systemic immune development and function through MyD88
signaling, some of the immunological defects reported by studies in MyD88-knockout mice
may reflect the absence of this beneficial influence. Second, certain TLRs might have, in
part, evolved to aid in communication with the commensal microbiota rather than to
recognize and respond to infectious agents12.
Hill et al.2 provide compelling evidence that perturbations to the microbiota are sufficient to
promote the development of allergic disease. However, future studies should address
whether the susceptibility to allergic disease persists after cessation of antibiotic treatment.
Are there lasting effects to host immune function after disruption of the microbiota? If not, it
would suggest multiple factors are at play in the development of hygiene-meditated atopic
disease, as it does not seem likely that allergies simply arise after an unfortunate coincidence
of allergen exposure during antibiotic treatment. Rather, allergy susceptibility may reflect a
combination of multiple environmental ‘hits’ to the microbiota, including antibiotics,
infection and diet changes, paired with possible genetic defects in the host that prevent
appropriate recovery of the microbiota after disruption. This study, supported by dozens of
epidemiological reports, strongly urges the consideration of host genetic factors associated
with allergic disease in the context of their possible role in mediating host-microbe
symbiosis13. On the basis of these emerging findings, consideration should be given to the
microbiota hypothesis as a basis for observations linking microbes to immune-mediated
diseases rather than a view of infectious agents affecting allergy.
Although infectious diseases remain a substantial threat to human health, especially in this
age of antibiotic-resistant ‘superbugs’, we are becoming ever more aware of the dramatic
contribution of microbes to host physiology. Appropriately, we are now starting to realize a
role for various immune factors, such as TLRs, previously considered only in the context of
pathogen eradication, in maintaining and promoting host-microbe symbiosis. With these
new insights compelling us to consider the microbiota as part of the organismal unit, we
have the potential of redefining and discovering many aspects of our biology.
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Fig. 1.
Hill et al.2 show that the absence of MyD88-dependent microbial stimulation promotes IgE
production by B cells, resulting in basophil expansion in the bone marrow and subsequent
susceptibility to allergic disease. In this model, intestinal bacteria are depicted as the source
of microbial products that induce antiallergic immune responses; however, microbes at other
anatomical locations may affect T helper type 2 (TH2) immunity. PAMP, pathogen-
associated molecular pattern; PMN, polymorphonuclear cell.
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